A new assessment strategy Last academic year, after a discussion with my head of department, I arranged a poster presentation assessment. This required students to work in pairs and design a poster ...
Posters will be grouped together by college, and each poster will be assigned a unique location number. The poster presentation schedule will be available on the Symposium website no later than Friday ...
Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...
We appreciate your interest in applying to submit a poster presentation for the 2025 Office of Interdisciplinary Graduate Program's (OIGP) Spring Reception. Our reception will take place in-person ...
Palisade Bio is a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The ...
Abstract Title: Briquilimab Potently Inhibits Stem Cell Factor (SCF)/c-Kit Signaling and Induces Mast Cell Apoptosis Poster Number: 541 Session Title: Novel Mechanisms of Mast Cells, Basophils and IgE ...
TYRA-430 is an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers. The US Food and Drug Administration has cleared Tyra's Investigational New Drug application to ...
Presenters are kindly asked not to exceed the size of the board. Posters presented in the Sessions are asked to be set-up during the lunch break on the day of presentation. Posters must be taken down ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback